Boston Trust Walden’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-632
Closed -$249K 395
2021
Q3
$249K Hold
632
﹤0.01% 367
2021
Q2
$291K Hold
632
﹤0.01% 357
2021
Q1
$236K Sell
632
-540
-46% -$220K ﹤0.01% 357
2020
Q4
$422K Hold
1,172
﹤0.01% 329
2020
Q3
$352K Sell
1,172
-18
-2% -$6.2K ﹤0.01% 333
2020
Q2
$429K Buy
+1,190
New +$383K 0.01% 322

Other funds holding ILMN

Boston Trust Walden's ILMN Position: Q4 2021 in Review

Boston Trust Walden sold out of Illumina (ILMN) in Q4 2021, closing a stake of 632 shares — an estimated $249K sold.

Boston Trust Walden first reported a position in ILMN in Q2 2020 and held it in 6 quarters. The position peaked at $429K in Q2 2020. 1,066 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

  • Boston Trust Walden reported no remaining Illumina position as of Q4 2021 after selling out during the quarter.
  • Boston Trust Walden sold 632 Illumina shares in Q4 2021, an estimated $249K.
  • Boston Trust Walden first reported a position in Illumina in Q2 2020 and held it in 6 quarters.
  • Boston Trust Walden's Illumina position peaked at $429K in Q2 2020.
  • 1,066 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Boston Trust Walden's 13F filing for Q4 2021, filed 21 Jan 2022.